Plasma osteopontin is a biomarker for the severity of alcoholic liver cirrhosis, not for hepatocellular carcinoma screening

BACKGROUND: Implementation of surveillance programs for at-risk populations and identification of biomarkers for early hepatocellular carcinoma (HCC) detection are a major public health goal. Recently, osteopontin (OPN) has attracted attention as a promising biomarker, with some potential advantages...

Descripción completa

Detalles Bibliográficos
Autores principales: Simão, Adélia, Madaleno, João, Silva, Nuno, Rodrigues, Fernando, Caseiro, Paula, Costa, José Nascimento, Carvalho, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487194/
https://www.ncbi.nlm.nih.gov/pubmed/26122937
http://dx.doi.org/10.1186/s12876-015-0307-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487194/
https://www.ncbi.nlm.nih.gov/pubmed/26122937
http://dx.doi.org/10.1186/s12876-015-0307-1

Ejemplares similares